19-Mar-2026
Major Investor Makes Bold New Bet on Phreesia Stock
TipRanks (Thu, 19-Mar 10:08 PM ET)
Phreesia and Sesame Workshop Win Point of Care Excellence Award for Best Unbranded Campaign
Business Wire (Thu, 19-Mar 9:03 PM ET)
Phreesia Secures New $275 Million Revolving Credit Facility
TipRanks (Mon, 16-Mar 4:41 PM ET)
Phreesia Announces Refinancing of Bridge Loan with New $275 Million Revolving Credit Facility
Business Wire (Mon, 16-Mar 4:03 PM ET)
Phreesia's Tiffany McGee Named a Top Woman Leader in Software
Business Wire (Thu, 12-Mar 4:06 PM ET)
Phreesia Named to the 2026 Capterra Shortlist for Appointment Scheduling
Business Wire (Tue, 10-Mar 4:06 PM ET)
Phreesia's Tara Sheehy Named to MM+M Women to Watch
Business Wire (Thu, 5-Mar 4:05 PM ET)
Business Wire (Tue, 3-Mar 6:52 AM ET)
Phreesia Appoints Jon Kessler to Board of Directors
Business Wire (Mon, 23-Feb 4:03 PM ET)
Business Wire (Wed, 18-Feb 2:29 PM ET)
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of March 19, 2026, PHR stock price climbed to $11.77 with 3,287,794 million shares trading.
PHR has a beta of 0.92, meaning it tends to be less sensitive to market movements. PHR has a correlation of 0.11 to the broad based SPY ETF.
PHR has a market cap of $709.58 million. This is considered a Small Cap stock.
Last quarter Phreesia reported $120 million in Revenue and $.07 earnings per share. This beat revenue expectation by $263,084 and missed earnings estimates by -$.17.
In the last 3 years, PHR traded as high as $36.13 and as low as $10.75.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): VTI, IWM, VB, VXF, IWO.
PHR has underperformed the market in the last year with a return of -59.4%, while the SPY ETF gained +17.6%. In the last 3 month period, PHR fell short of the market, returning -28.9%, while SPY returned -3.1%. However, in the most recent 2 weeks PHR has outperformed the stock market by returning -2.6%, while SPY returned -3.2%.
PHR support price is $10.80 and resistance is $11.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.
